help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harju, T.
Right arrow Articles by Kinnula, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harju, T.
Right arrow Articles by Kinnula, V. L.
American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 754-759, (2002)
© 2002 American Thoracic Society

Original Article

Diminished Immunoreactivity of {gamma}-Glutamylcysteine Synthetase in the Airways of Smokers' Lung

Terttu Harju, Riitta Kaarteenaho-Wiik, Ylermi Soini, Raija Sormunen and Vuokko L. Kinnula

Departments of Internal Medicine and Pathology, University of Oulu, Oulu University Hospital; and Biocenter of Oulu, Oulu, Finland

Correspondence and requests for reprints should be addressed to Professor Vuokko L. Kinnula, Department of Internal Medicine, University of Oulu, P.O. Box 5000, 90014, Oulu, Finland. E-mail: vuokko.kinnula{at}oulu.fi

Glutathione (GSH) plays a major role in protecting the airways against oxidative stress. The rate-limiting enzyme in de novo GSH synthesis is {gamma}-glutamylcysteine synthetase ({gamma}-GCS), which is induced by acute exposure to GSH-depleting cytokines and oxidants, but downregulated by transforming growth factor ß and prolonged oxidant exposure, at least in vitro. Cell-specific expression or regulation of {gamma}-GCS may play an important role both in the defense against oxidants and in the pathogenesis of oxidant-associated airway diseases. In this study, the localizations of {gamma}-GCS heavy ({gamma}-GCS-HS) and light ({gamma}-GCS-LS) subunits were investigated by immunohistochemistry in 22 patients with chronic obstructive pulmonary disease (COPD), 20 smokers without COPD, and 13 lifelong nonsmokers. The ultrastructural distributions of both {gamma}-GCS subunits were assessed by immuno–electron microscopy. Both subunits were expressed most prominently in the large airways, and their ultrastructural localization was both cytoplasmic and along the plasma membrane. The expression of {gamma}-GCS-HS was stronger in the central bronchial epithelium than in the peripheral bronchioli (p = 0.020), or in alveolar macrophages (p = 0.008). The expression of {gamma}-GCS-HS in the central bronchial epithelium showed a tendency to be higher in nonsmokers compared with all smokers (p = 0.052). Alveolar macrophages of nonsmokers had higher levels of {gamma}-GCS-HS (p = 0.001) and {gamma}-GCS-LS (p = 0.001) than did smokers. The expression of {gamma}-GCS-HS in the central bronchial epithelium was more marked in nonsmokers than in patients with COPD (p = 0.015), the difference between smokers and patients with COPD was not significant. In conclusion, the heavy and light subunits of {gamma}-GCS are mainly expressed in the large airways. Their tendency to decrease in cigarette smokers may further predispose lung cells to ongoing oxidant stress, which contributes to the progression of lung injury.

Key Words: {gamma}-glutamylcysteine synthetase • smoking • chronic obstructive pulmonary disease • oxidant • glutathione




This article has been cited by other articles:


Home page
 Therapeutic Advances in Respiratory DiseaseHome page
I. Rahman
Review: Antioxidant therapeutic advances in COPD
Therapeutic Advances in Respiratory Disease, December 1, 2008; 2(6): 351 - 374.
[Abstract] [PDF]

Home page
 ThoraxHome page
A R Bentley, P Emrani, and P A Cassano
Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review
Thorax, November 1, 2008; 63(11): 956 - 961.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Chappell, L. Daly, K. Morgan, T. Guetta-Baranes, J. Roca, R. Rabinovich, J. Lotya, A. B. Millar, S. C. Donnelly, V. Keatings, et al.
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD
Eur. Respir. J., October 1, 2008; 32(4): 931 - 937.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. Malhotra, R. Thimmulappa, A. Navas-Acien, A. Sandford, M. Elliott, A. Singh, L. Chen, X. Zhuang, J. Hogg, P. Pare, et al.
Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 592 - 604.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Siedlinski, D. S. Postma, C. C. van Diemen, A. Blokstra, H. A. Smit, and H. M. Boezen
Lung Function Loss, Smoking, Vitamin C Intake, and Polymorphisms of the Glutamate-Cysteine Ligase Genes
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 13 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Kode, S. Rajendrasozhan, S. Caito, S.-R. Yang, I. L. Megson, and I. Rahman
Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L478 - L488.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
I. Rahman and I. M. Adcock
Oxidative stress and redox regulation of lung inflammation in COPD.
Eur. Respir. J., July 1, 2006; 28(1): 219 - 242.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
V L Kinnula
Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases
Thorax, August 1, 2005; 60(8): 693 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
T. Harju, R. Kaarteenaho-Wiik, R. Sirvio, P. Paakko, J.D. Crapo, T.D. Oury, Y. Soini, and V.L. Kinnula
Manganese superoxide dismutase is increased in the airways of smokers' lungs
Eur. Respir. J., November 1, 2004; 24(5): 765 - 771.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
R. Kaarteenaho-Wiik and V. L. Kinnula
Distribution of Antioxidant Enzymes in Developing Human Lung, Respiratory Distress Syndrome, and Bronchopulmonary Dysplasia
J. Histochem. Cytochem., September 1, 2004; 52(9): 1231 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Neurohr, A-G. Lenz, I. Ding, H. Leuchte, T. Kolbe, and J. Behr
Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers
Eur. Respir. J., July 1, 2003; 22(1): 82 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002
Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. S. Hiemstra
The Adaptive Response of Smokers to Oxidative Stress: Moving from Culture to Tissue
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 635 - 636.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2002 American Thoracic Society 		  ATS State of the Art 2009